Filing Details
- Accession Number:
- 0001209191-10-024066
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-28 13:00:00
- Reporting Period:
- 2010-04-27
- Filing Date:
- 2010-04-28
- Accepted Time:
- 2010-04-28 17:51:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1266275 | Kate Mitchell | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No | |
1279735 | C Louis Bock | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No | |
1308328 | Bavp, L.p. | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No | |
1308343 | Scale Venture Management I, Llc | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No | |
1366969 | Rory O'driscoll | 950 Tower Lane, Suite 700 Foster City CA 94404 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-27 | 1,649,358 | $0.00 | 1,649,358 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2010-04-27 | 1,121,866 | $0.00 | 2,771,224 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2010-04-27 | 1,153,719 | $0.00 | 3,924,943 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2010-04-27 | 574,515 | $0.00 | 4,499,458 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2010-04-27 | 363,636 | $11.00 | 4,863,094 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Preferred Stock | Disposition | 2010-04-27 | 1,562,184 | $0.00 | 1,649,358 | $0.00 |
Common Stock | Series B Convertible Preferred Stock | Disposition | 2010-04-27 | 1,121,866 | $0.00 | 1,121,866 | $0.00 |
Common Stock | Series C Convertible Preferred Stock | Disposition | 2010-04-27 | 1,153,719 | $0.00 | 1,153,719 | $0.00 |
Common Stock | Series C-1 Convertible Preferred Stock | Disposition | 2010-04-27 | 574,515 | $0.00 | 574,515 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Automatic conversion, in connection with the Issuer's initial public offering, of 1,562,184 shares of Series A Preferred Stock into 1,649,358 shares of common stock.
- The shares are held by BAVP, LP ("BAVP"). The General Partner of BAVP is Scale Venture Management I, LLC ("Scale"). Louis Bock, Kate Mitchell, Rory O'Driscoll and Mark Brooks are managing members of Scale and share voting and investment power with respect to these shares. Each of the managing members of Scale disclaims beneficial ownership with respect to these shares except to the extent of their pecuniary interest therein.
- Automatic conversion, in connection with the Issuer's initial public offering, of Series B Preferred Stock at a rate of 1-for-1, resulting in the issuance of 1,121,866 shares of common stock.
- The Series B Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
- Automatic conversion, in connection with the Issuer's initial public offering, of Series C Preferred Stock at a rate of 1-for-1, resulting in the issuance of 1,153,719 shares of common stock.
- The Series C Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
- Automatic conversion, in connection with the Issuer's initial public offering, of Series C-1 Preferred Stock at a rate of 1-for-1, resulting in the issuance of 574,515 shares of common stock.
- The Series C-1 Convertible Preferred Stock converted into the Issuer's Common Stock at a rate of 1-for-1.
- The securities are preferred stock of the Issuer and do not have an expiration date. The securities automatically converted into common stock upon the closing of the Issuer's initial public offering.